During the past decade, Complex Oncology Center - Plovdiv EOOD conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 3 clinical trials were completed, i.e. on average, 15.8% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 2 clinical trials were completed. i.e. 22.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Complex Oncology Center - Plovdiv EOOD" #1 sponsor was "Hoffmann-La Roche" with 5 trials, followed by "Janssen Research & Development, LLC" with 4 trials sponsored, "Pfizer" with 4 trials sponsored, "Astex Pharmaceuticals, Inc." with 2 trials sponsored and "Incyte Corporation" with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Complex Oncology Center - Plovdiv EOOD" #1 collaborator was "Astellas Pharma Inc" with 1 trials as a collaborator, "BioGene Pharmaceutical Inc." with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Foundation Medicine, Inc." with 1 trials as a collaborator and "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Complex Oncology Center - Plovdiv EOOD" are "Non-Small Cell Lung Cancer" (3 trials), "Acute Myeloid Leukemia" (2 trials), "Melanoma" (2 trials), "Myelodysplastic Syndromes" (2 trials) and "Neoplasms" (2 trials). Many other conditions were trialed in "Complex Oncology Center - Plovdiv EOOD" in a lesser frequency.

Most popular intervention types in "Complex Oncology Center - Plovdiv EOOD" are "Drug" (18 trials), "Biological" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (4 trials), "ASTX727" (2 trials), "Bevacizumab" (2 trials), "Docetaxel" (2 trials) and "Encorafenib" (2 trials). Other intervention names were less common.

The vast majority of trials in "Complex Oncology Center - Plovdiv EOOD" are 15 trials for "All" genders, 4 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Complex Oncology Center - Plovdiv EOOD". undefined are not yet recruiting, 8 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Complex Oncology Center - Plovdiv EOOD, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Complex Oncology Center - Plovdiv EOOD, 5 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".